Efficacy and Safety of Daclatasvir and Asunaprevir in Patients with Hepatitis C Virus Genotype 1b Infection on Hemodialysis

BACKGROUND/AIMS: We evaluated the efficacy and safety of daclatasvir (DCV) and asunaprevir (ASV) in patients with chronic hepatitis C virus (HCV) infection on hemodialysis. METHODS: We performed a single-arm, multicenter prospective study. Twenty-one chronic hemodialysis patients with HCV infection...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Byung Seok, Song, Myeong Jun, Kwon, Jung Hyun, Lee, Tae Hee, Jang, Ji Woong, Kim, Seok Hyun, Lee, Sae Hwan, Kim, Hong Soo, Kim, Ji Hoon, Kim, Seok Bae, Ko, Soon Young, Song, Do Seon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430432/
https://www.ncbi.nlm.nih.gov/pubmed/30400729
http://dx.doi.org/10.5009/gnl18240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430432/
https://www.ncbi.nlm.nih.gov/pubmed/30400729
http://dx.doi.org/10.5009/gnl18240

Ejemplares similares